| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 10 |
| 1 | OMEPRAZOLE | 8 |
| 2 | OMEPRAZOLE MAGNESIUM | 8 |
| 3 | CYCLOPHOSPHAMIDE | 7 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 7 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 7 |
| 6 | PREDNISOLONE | 7 |
| 7 | PREDNISOLONE ORAL | 7 |
| 8 | PREDNISOLONE ORAL SOLUTION | 7 |
| 9 | ASPIRIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CIDOFOVIR ANHYDROUS | 1 | 0.0007 |
| 1 | GIVOSIRAN SODIUM | 1 | 0.0006 |
| 2 | BREXUCABTAGENE AUTOLEUCEL | 1 | 0.0005 |
| 3 | GOLIMUMAB | 5 | 0.0004 |
| 4 | ELOTUZUMAB | 2 | 0.0004 |
| 5 | TAFLUPROST | 1 | 0.0003 |
| 6 | NALOXEGOL OXALATE | 1 | 0.0003 |
| 7 | TIOTROPIUM BROMIDE AND OLODATEROL | 1 | 0.0002 |
| 8 | RALTEGRAVIR | 1 | 0.0002 |
| 9 | TASIMELTEON | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 2 | 0.0004 |
| 1 | Hedgehog Pathway Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 3 | Anti-anginal [EPC] | 1 | 0.0001 |
| 4 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |
| 5 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 7 | Interleukin-23 Antagonist [EPC] | 7 | 0.0001 |
| 8 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 9 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |